AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimirun M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Avonic Life Sciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimirun M 2mg/500mg Tablet ER

Diabex Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan involving diet, exercise, and weight management as advised by your doctor; lifestyle choices are vital to controlling diabetes. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and how to manage them. Maintain regular meals and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimirun M 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimirun M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimirun M 2mg/500mg Extended-Release tablet whole; do not alter its form by chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimirun M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimirun M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Glimirun M 2mg/500mg Extended-Release Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consume with food.

How Glimirun M 2mg/500mg Tablet ER works:

Glimirun M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimirun M 2mg/500mg Extended-Release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimirun M 2mg/500mg tablets might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimirun M 2mg/500mg tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimirun M 2mg/500mg Extended-Release tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Avoid administering Glimirun M 2mg/500mg Extended-Release tablets to patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimirun M 2mg/500mg Extended-Release tablets to patients with hepatic impairment. Dosage modifications may be necessary. Physician consultation is advised. Initiate treatment with a reduced dose in patients exhibiting mild to moderate liver dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Glimirun M 2mg/500mg Tablet ER :

Should you forget to take your Glimirun M 2mg/500mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimirun M 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimirun M 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimirun M 2mg/500mg Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimirun M 2mg/500mg Tablet ER and seek immediate medical attention.
Glimirun M 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimirun M 2mg/500mg Tablet ER may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimirun M 2mg/500mg Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glimirun M 2mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimirun M 2mg/500mg Tablet ER with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimirun M 2mg/500mg Tabl...
56
MRP 65
13% off